Silvia Muro Selected Research

Type B Niemann-Pick Disease

11/2017	ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement.
1/2017	Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice.
5/2008	Delivery of acid sphingomyelinase in normal and niemann-pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Muro Research Topics

Disease

12	Inflammation (Inflammations) 10/2020 - 05/2003
11	Niemann-Pick Diseases (Niemann Pick Disease) 04/2022 - 01/2006
5	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2016 - 08/2008
4	Type A Niemann-Pick Disease 01/2019 - 08/2014
3	Neoplasms (Cancer) 02/2021 - 06/2017
3	Type B Niemann-Pick Disease 11/2017 - 05/2008
3	Ischemia 01/2016 - 02/2012
3	Fabry Disease (Fabry's Disease) 02/2014 - 02/2011
2	Thrombosis (Thrombus) 07/2015 - 07/2004
1	Mucopolysaccharidoses 04/2022
1	Pneumonia (Pneumonitis) 01/2018
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 12/2016
1	Neuroblastoma 04/2015
1	Glycogen Storage Disease Type II (Pompe's Disease) 07/2012
1	Lung Diseases (Lung Disease) 09/2008
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2008
1	Reperfusion Injury 04/2003

Drug/Important Bio-Agent (IBA)

15	AcidsIBA 04/2022 - 01/2006
13	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2022 - 01/2006
13	EnzymesIBA 10/2020 - 01/2006
10	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2020 - 05/2003
5	Proteins (Proteins, Gene)FDA Link 02/2021 - 07/2012
5	Pharmaceutical PreparationsIBA 07/2015 - 05/2003
4	PolymersIBA 02/2021 - 05/2008
3	SphingomyelinsIBA 01/2019 - 05/2015
3	ClathrinIBA 05/2015 - 01/2006
3	GalactosidasesIBA 02/2014 - 02/2011
2	neodymium pyrocatechin disulfonate (NPD)IBA 05/2015 - 05/2008
2	AntibodiesIBA 05/2013 - 09/2008
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 04/2022
1	SubtilisinIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2020
1	Tocopherols (Tocopherol)IBA 01/2019
1	Superoxide DismutaseIBA 01/2018
1	Interferon-betaIBA 01/2018
1	EndotoxinsIBA 01/2018
1	Interleukin-27 (Interleukin 27)IBA 01/2018
1	LipidsIBA 12/2016
1	Superoxides (Superoxide)IBA 01/2016
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 07/2015
1	DextranaseIBA 04/2015
1	Polystyrenes (Polystyrene)IBA 04/2015
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 08/2014
1	Radioisotopes (Radionuclides)IBA 10/2012
1	GlycogenIBA 07/2012
1	alpha-Glucosidases (Acid Maltase)IBA 07/2012
1	GlucosidasesIBA 07/2012
1	globotriaosylceramide (globotriosylceramide)IBA 02/2011
1	Drug CarriersIBA 09/2008
1	Glycoproteins (Glycoprotein)IBA 01/2006
1	Cell Adhesion MoleculesIBA 01/2006
1	CatalaseIBA 04/2003
1	AntioxidantsIBA 04/2003

Therapy/Procedure

3	Therapeutics 12/2016 - 01/2008
3	Enzyme Replacement Therapy 12/2016 - 01/2006
1	Intravenous Injections 10/2020
1	Drug Therapy (Chemotherapy) 07/2015